These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18562035)

  • 1. Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents.
    Neubert A; Sternberg K; Nagel S; Harder C; Schmitz KP; Kroemer HK; Weitschies W
    J Control Release; 2008 Aug; 130(1):2-8. PubMed ID: 18562035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell.
    Seidlitz A; Nagel S; Semmling B; Grabow N; Martin H; Senz V; Harder C; Sternberg K; Schmitz KP; Kroemer HK; Weitschies W
    Eur J Pharm Biopharm; 2011 May; 78(1):36-48. PubMed ID: 21182943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of different tissue-simulating hydrogel compartments on in vitro release and distribution from drug-eluting stents.
    Semmling B; Nagel S; Sternberg K; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):570-8. PubMed ID: 24801065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Dissolution Vessel Geometry and Dissolution Medium on In Vitro Dissolution Behaviour of Triamterene-Coated Model Stents in Different Test Setups.
    Pruessmann K; Wentzlaff M; Schilling R; Seidlitz A
    AAPS PharmSciTech; 2019 Jan; 20(1):27. PubMed ID: 30604074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel "plum pudding" gels as potential drug-eluting stent coatings: controlled release of fluvastatin.
    McGillicuddy FC; Lynch I; Rochev YA; Burke M; Dawson KA; Gallagher WM; Keenan AK
    J Biomed Mater Res A; 2006 Dec; 79(4):923-33. PubMed ID: 16941598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
    Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing.
    Semmling B; Nagel S; Sternberg K; Weitschies W; Seidlitz A
    AAPS PharmSciTech; 2013 Sep; 14(3):1209-18. PubMed ID: 23918507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.
    Seidlitz A; Weitschies W
    J Pharm Pharmacol; 2012 Jul; 64(7):969-85. PubMed ID: 22686343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating.
    Sirianni RW; Jang EH; Miller KM; Saltzman WM
    J Control Release; 2010 Mar; 142(3):474-82. PubMed ID: 19958804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design.
    Hezi-Yamit A; Sullivan C; Wong J; David L; Chen M; Cheng P; Shumaker D; Wilcox JN; Udipi K
    J Biomed Mater Res A; 2009 Jul; 90(1):133-41. PubMed ID: 18491390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional compositional analysis of drug eluting stent coatings using cluster secondary ion mass spectrometry.
    Mahoney CM; Fahey AJ; Belu AM
    Anal Chem; 2008 Feb; 80(3):624-32. PubMed ID: 18179243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier free rapamycin loaded drug eluting stent: in vitro and in vivo evaluation.
    Khan W; Farah S; Nyska A; Domb AJ
    J Control Release; 2013 May; 168(1):70-6. PubMed ID: 23462671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.